Last reviewed · How we verify
NCT05668728
Dry Needling for Myofascial Pain Syndrome
NA trial testing Group 1: Peppering in Myofascial Pain Syndromes in 45 participants. Completed in 15 April 2023.
15 February 2023
Quick facts
| Lead sponsor | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 1 January 2023 |
| Primary completion | 15 February 2023 |
| Estimated completion | 15 April 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Group 1: Peppering
- group 2: spin and wait
- group 3: Peppering and spin and wait
Conditions studied
- Myofascial Pain Syndromes — all drugs for Myofascial Pain Syndromes →
- Neck Pain — all drugs for Neck Pain →
Sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Who can join
Adults 18 to 65, any sex, with Myofascial Pain Syndromes or Neck Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Myofascial pain syndrome (MAS) is defined as a regional painful syndrome characterized by pain and tenderness in a muscle group or a muscle, a taut band within the muscle, pain reflected by pressing, and the presence of trigger points. It causes localized muscle pain in the shoulder and neck. The frequency of mas is around 12% in the normal population, and its frequency increases in those with chronic diseases. It is more common in the 30-60 age range and in the female population. Mechanical causes such as micro-macro trauma, nociceptive disorders, physical fatigue, psychological stress and genetic factors are blamed in its etiopathogenesis. Painful myofascial trigger points may occur by pressing on all muscles in the body, although it is more common in the trazius muscle, especially in those who work at a desk, who are constantly in a certain position, and who are sedentary. Myofascial trigger points are often detected by examination.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05668728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myofascial Pain Syndromes
Currently open trials in the same condition.
- NCT07525921 — Immediate Effect of Dry Needling on Calf Muscles Pain Pressure Threshold,Sprint Speed and Functional Performance in Amat · NA · recruiting
Other Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials
Trials by the same sponsor.
- NCT07467681 — Perioperative Hypothermia and Sevoflurane Consumption in Elderly Patients · not yet recruiting
- NCT07456748 — Investigation of the Association Between Upper Crossed Syndrome and Temporomandibular Joint Dysfunction in University St · completed
- NCT07128979 — Efficacy and Safety Evaluation of Ruscus Aculeatus L in Patients With Hemorrhoids · Phase 4 · recruiting
- NCT07170449 — Investigation of the Relationship Between Ultrasonographic Parameters and Tactile Sensation in Carpal Tunnel Syndrome · recruiting
- NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05668728 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Last refreshed: 30 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05668728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing